insights_auto
Why is GLENMARK down 3.61%?
Dive Deeperchevron_right
GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,199.90
arrow_downward
-3.61%(-82.40) 1D
Oct 8, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,280.00
High
₹2,284.00
Low
₹2,181.20
Mkt. cap
626.11B
Avg. vol.
582.74K
Volume
816.49K
Dividend
0.23%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
34.54
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,280.00
High
₹2,284.00
Low
₹2,181.20
Mkt. cap
626.11B
Avg. vol.
582.74K
Volume
816.49K
Dividend
0.23%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
34.54
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
marketscreener.com
·
20 minutes ago
US Equity Indexes Drop as Sharp Sell-Off in Semiconductor Heavyweights Sinks Technology While Crude Oil Surges
ChartMill
·
50 minutes ago
Exploring the top movers within the dow jones index during today's session.
Forbes
·
1 hour ago
The S&P 500 Yields Barely 1%. Income Investors Need A New Playbook
FOREX.com
·
27 minutes ago
S&P 500 Pulls Back From Another Fresh ATH As Yields Soften
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees16.9K
FoundedNov 18, 1977
Headquarters-
SectorPharmaceutical industry
Websiteglenmarkpharma.com